PDL BioPharma Inc.

PDL BioPharma Completes December 15 Special Dividend Payment.
Biotech Week; 12/30/2009; 870 words; PDL BioPharma, Inc. (PDL) (NASDAQ:PDLI) announced that it has paid the December 15...to each stockholder of the Company's stock in 2009 (see also PDL BioPharma, Inc.). As previously announced, the conversion rate for the Company...

Research and Markets Adds Report: Monoclonal Antibody Based Products - Global Trends.
Health & Beauty Close-Up; 12/29/2009; 540 words; ...Biotech Products, L.P. (US) - Medarex, Inc. (US) - MedImmune, Inc. (US) - PDL BioPharma (US) - Schering-Plough Corp. (US) - Strategic Diagnostics Inc (US) - UCB Group (Belgium) - Wyeth Pharmaceuticals...

FORM 8-K: PDL BIOPHARMA ANNOUNCES REGULATION FD DISCLOSURE
US Fed News Service, Including US State News; 12/24/2009; 478 words; WASHINGTON, Dec. 22 -- PDL BioPharma, Inc., Incline Village, Nev., files Form 8-K...name of registrant as specified in its charter is PDL BioPharma, Inc. State of Incorporation: Delaware Regulation FD...

Research and Markets: Monoclonal Antibody Based Products - A Comprehensive Report on the Global Trends in this Industry.
Business Wire; 12/22/2009; 589 words; ...Biotech Products, L.P. (US) * Medarex, Inc. (US) * MedImmune, Inc. (US) * PDL BioPharma (US) * Schering-Plough Corporation (US) * Strategic Diagnostics Inc (US) * UCB Group (Belgium) * Wyeth Pharmaceuticals...

Lilly licenses PDL type 1 diabetes drug candidate
AP Online; 12/21/2009; 486 words; PDL BioPharma Inc. said Monday that Eli Lilly & Co...for newly diagnosed type 1 diabetes. PDL said Lilly and its partner MacroGenics...Incline Village, Calif.-based PDL BioPharma rose 20 cents, or 2.9 percent, to...